DCF — DENVER HEALTH MEDICAL CENTER
Enterprise Value: $-1.5B
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-1.5B
Enterprise Value
$-471.0M
PV of Cash Flows
$-993.5M
PV of Terminal Value
$-1.6B
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $1.1B | $-87.0M | -8.0% | $-135.5M | $-123.2M |
| Year 2 | $1.2B | $-77.9M | -7.0% | $-127.8M | $-105.6M |
| Year 3 | $1.2B | $-68.1M | -6.0% | $-119.5M | $-89.8M |
| Year 4 | $1.3B | $-63.8M | -5.0% | $-116.8M | $-79.8M |
| Year 5 | $1.3B | $-62.5M | -5.0% | $-117.1M | $-72.7M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-1.5B. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$1.1B
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.08104219559271383
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5